Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01006031
Recruitment Status : Completed
First Posted : November 2, 2009
Last Update Posted : December 30, 2011
Information provided by (Responsible Party):
Antonio Rivero, Sociedad Andaluza de Enfermedades Infecciosas

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2011
  Actual Study Completion Date : December 2011